Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GO 4

Drug Profile

GO 4

Alternative Names: GO-4

Latest Information Update: 27 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator General Oncology
  • Class Antineoplastics; Aromatic amino acids; Corrinoids; Furans; Myeloablative agonists; Nitrogen mustard compounds; Nitrosourea compounds; Small molecules; Sugar acids; Vitamin B12 analogues; Vitamins
  • Mechanism of Action Alkylating agents; DNA damage stimulants; DNA synthesis inhibitors; Immunosuppressants; Nitric oxide inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Cancer

Most Recent Events

  • 18 Oct 2025 Adverse events and efficacy data from a phase I SHARON trial in Cancer (Metastatic disease) released by General Oncology
  • 08 Apr 2025 General Oncology has patent protection for GO 4 for the treatment of cancer, prior to April 2025 (General Oncology website, April 2025)
  • 08 Apr 2025 General Oncology plans an End-of-Phase I FDA meeting in Q3 2025 (General Oncology pipeline, April 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top